WAM
AXDX

Warberg Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

Warberg Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,000
Closed -$19.8K – 225
2024
Q1 		$19.8K Buy
+20,000
New +$31.6K ﹤0.01% 152

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Warberg Asset Management's AXDX Position: Q2 2024 in Review

Warberg Asset Management sold out of Accelerate Diagnostics (AXDX) in Q2 2024, closing a stake of 20,000 shares — an estimated $19.8K sold.

Warberg Asset Management first reported a position in AXDX in Q1 2024 and held it in 1 quarter. The position peaked at $19.8K in Q1 2024. 41 funds tracked by Wall St. Rank hold AXDX as of Q2 2024.

  • Warberg Asset Management reported no remaining Accelerate Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Warberg Asset Management sold 20,000 Accelerate Diagnostics shares in Q2 2024, an estimated $19.8K.
  • Warberg Asset Management first reported a position in Accelerate Diagnostics in Q1 2024 and held it in 1 quarter.
  • Warberg Asset Management's Accelerate Diagnostics position peaked at $19.8K in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2024.

Based on Warberg Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.